Beyond the Funding: Recognising Women’s Role in UK Biotech Growth

The talent is there. The opportunity needs to follow.

Women in UK biotech are not short of ideas. From drug discovery and advanced therapies to AI-led research, female founders are building businesses with genuine commercial potential. The bigger question is whether the sector is creating enough opportunities for those careers and companies to keep moving forward.

The latest Women in Innovation programme has again highlighted the strength of female-led innovation. Since 2016, more than £15 million in grants have supported over 260 winners, while the proportion of successful women-led applications across Innovate UK competitions has increased from one in seven to one in three.

That matters to biotech employers because early support can shape the talent pipeline much further down the line.

Where commercial talent can make a difference

For hiring managers, the conversation should not stop with scientific leadership. As biotech companies move from research towards clinical development, partnering and commercialisation, they need people who can turn strong science into sustainable growth.

This is where commercial roles become particularly interesting.

Business development, market access, commercial strategy and partnerships all require a mix of scientific understanding and commercial judgement. Women with experience across these areas can bring valuable perspectives as companies prepare for licensing discussions, build partnerships or take products closer to market.

Recent UK biotech leadership data also points towards movement in this area. Female representation among Chief Business Officers reached 34% in 2025, while female CEO representation remained much lower at 18.7%.

For Biotech Recruiters, this creates an interesting picture. There is a growing pool of commercially experienced women, yet progression into the very top leadership positions remains slower.

Retention starts before the job offer

In recruitment conversations, candidates often look beyond salary when considering their next move. They want to understand how a company operates day to day. How much autonomy will they have? Will their voice carry weight in senior meetings? Is there a realistic route to progression?

These questions can be especially relevant for women moving into senior commercial positions within growing biotech businesses.

A strong candidate may accept an offer because of the science, the pipeline or the leadership team. They are more likely to stay when the working environment continues to match what was discussed during the hiring process.

That makes retention part of biotech recruitment, rather than something to consider after someone has joined.

Keeping the pipeline moving

The UK life sciences sector is expected to need thousands of additional skilled workers over the coming decade. Building that workforce means making good use of the talent already coming through the industry.

Women in Innovation programmes can help open the door. Biotech employers then have a role in keeping that door open through meaningful career opportunities, visible leadership pathways and fair access to commercial progression.

At Zenopa, we work with life science, medical device and pharmaceutical organisations across the US, EU and UK.

For more information, please visit the Life Science recruitment page or get in touch!

Perhaps the most encouraging sign is that the conversation is shifting. Women are already building, leading and commercialising biotech businesses across the UK. The next step is making sure the wider talent market reflects that momentum.